Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer

NCT06446206 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Platinum-sensitive Relapsed Ovarian Cancer

Interventions

DRUG: Adebrelimab, paclitaxel, carboplatin, bevacizumab, fluzoparib

Sponsor

The First Hospital of Jilin University